cells;id;gene;name;diffSig;sigl2FC
JURKAT;5879;RAC1;ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1);-9;-1.015187647
JURKAT;5294;PIK3CG;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma;-11;-0.783407084
JURKAT;4643;MYO1E;myosin IE;-5;-0.893055799
JURKAT;10844;TUBGCP2;tubulin, gamma complex associated protein 2;-4;-0.991608993
JURKAT;54101;RIPK4;receptor-interacting serine-threonine kinase 4;-5;-0.762642066
JURKAT;2845;GPR22;G protein-coupled receptor 22;-9;-0.631757194
JURKAT;81696;OR5V1;olfactory receptor, family 5, subfamily V, member 1;-10;-0.591446655
JURKAT;10574;CCT7;chaperonin containing TCP1, subunit 7 (eta);-4;-0.811692732
JURKAT;92;ACVR2A;activin A receptor, type IIA;-7;-0.586601593
JURKAT;26219;OR1J4;olfactory receptor, family 1, subfamily J, member 4;-4;-0.460360687
JURKAT;22885;ABLIM3;actin binding LIM protein family, member 3;-4;-0.861029648
JURKAT;55740;ENAH;enabled homolog (Drosophila);-7;-0.69537942
JURKAT;58529;MYOZ1;myozenin 1;-5;-0.61923971
JURKAT;1410;CRYAB;crystallin, alpha B;-3;-0.619712296
JURKAT;51701;NLK;nemo-like kinase;-3;-0.774343441
JURKAT;6708;SPTA1;spectrin, alpha, erythrocytic 1;-3;-0.698805992
JURKAT;395;ARHGAP6;Rho GTPase activating protein 6;-3;-0.693471102
JURKAT;81027;TUBB1;tubulin, beta 1 class VI;-5;-0.792610863
JURKAT;5311;PKD2;polycystic kidney disease 2 (autosomal dominant);-6;-0.599438758
JURKAT;23049;SMG1;SMG1 phosphatidylinositol 3-kinase-related kinase;-3;-0.47597889
JURKAT;9126;SMC3;structural maintenance of chromosomes 3;-5;-0.410052328
JURKAT;84451;KIAA1804;mixed lineage kinase 4;-5;-0.460214942
JURKAT;26211;OR2F1;olfactory receptor, family 2, subfamily F, member 1 (gene/pseudogene);-3;-0.557940157
JURKAT;134728;IRAK1BP1;interleukin-1 receptor-associated kinase 1 binding protein 1;-4;-0.327426997
JURKAT;4646;MYO6;myosin VI;-3;-0.329417096
JURKAT;2803;GOLGA4;golgin A4;-3;-0.800357092
JURKAT;10733;PLK4;polo-like kinase 4;-7;-0.640915218
JURKAT;10580;SORBS1;sorbin and SH3 domain containing 1;-4;-0.768417401
JURKAT;9293;GPR52;G protein-coupled receptor 52;-3;-0.501880529
JURKAT;54112;GPR88;G protein-coupled receptor 88;-3;-0.386401051
JURKAT;5747;PTK2;protein tyrosine kinase 2;-3;-0.533225997
JURKAT;4831;NME2;NME/NM23 nucleoside diphosphate kinase 2;-5;-0.63553375
JURKAT;27130;INVS;inversin;-4;-0.471010825
JURKAT;11337;GABARAP;GABA(A) receptor-associated protein;-3;-0.521636794
JURKAT;657;BMPR1A;bone morphogenetic protein receptor, type IA;-5;-0.486329774
JURKAT;79109;MAPKAP1;mitogen-activated protein kinase associated protein 1;-4;-0.643502003
JURKAT;11211;FZD10;frizzled class receptor 10;-3;-0.452102659
JURKAT;27347;STK39;serine threonine kinase 39;-4;-0.474822172
JURKAT;4916;NTRK3;neurotrophic tyrosine kinase, receptor, type 3;-3;-0.625664316
JURKAT;1063;CENPF;centromere protein F, 350/400kDa;-4;-0.293769521
JURKAT;8048;CSRP3;cysteine and glycine-rich protein 3 (cardiac LIM protein);-4;-0.402599595
JURKAT;84539;MCHR2;melanin-concentrating hormone receptor 2;-4;-0.491930486
JURKAT;3702;ITK;IL2-inducible T-cell kinase;-5;-0.771094322
JURKAT;283160;OR8D2;olfactory receptor, family 8, subfamily D, member 2 (gene/pseudogene);-3;-0.358338212
JURKAT;8477;GPR65;G protein-coupled receptor 65;-9;-0.482959583
JURKAT;10787;NCKAP1;NCK-associated protein 1;-5;-0.325703169
JURKAT;221395;ADGRF5;adhesion G protein-coupled receptor F5;-5;-0.58820763
JURKAT;1070;CETN3;centrin, EF-hand protein, 3;-4;-0.308546914
JURKAT;84066;TEX35;testis expressed 35;-4;-0.591233977
JURKAT;55971;BAIAP2L1;BAI1-associated protein 2-like 1;-3;-0.390021714
JURKAT;8325;FZD8;frizzled class receptor 8;-3;-0.354375636
JURKAT;2045;EPHA7;EPH receptor A7;-4;-0.897815406
JURKAT;5577;PRKAR2B;protein kinase, cAMP-dependent, regulatory, type II, beta;-4;-0.453190086
JURKAT;9252;RPS6KA5;ribosomal protein S6 kinase, 90kDa, polypeptide 5;-4;-0.615993267
JURKAT;146057;TTBK2;tau tubulin kinase 2;-5;-0.376877834
JURKAT;26750;RPS6KC1;ribosomal protein S6 kinase, 52kDa, polypeptide 1;-4;-0.56273929
JURKAT;8382;NME5;NME/NM23 family member 5;-4;-0.345885984
JURKAT;2263;FGFR2;fibroblast growth factor receptor 2;-4;-0.531733695
JURKAT;151525;WDSUB1;WD repeat, sterile alpha motif and U-box domain containing 1;-3;-0.466348729
JURKAT;1432;MAPK14;mitogen-activated protein kinase 14;-3;-0.482448801
JURKAT;5290;PIK3CA;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha;-4;-0.447141086
JURKAT;54443;ANLN;anillin, actin binding protein;-3;-0.391727728
JURKAT;11213;IRAK3;interleukin-1 receptor-associated kinase 3;-4;-0.260213382
JURKAT;10810;WASF3;WAS protein family, member 3;-3;-0.260458694
JURKAT;11127;KIF3A;kinesin family member 3A;-3;-0.414068122
JURKAT;57512;GPR158;G protein-coupled receptor 158;-4;-0.362912122
JURKAT;134864;TAAR1;trace amine associated receptor 1;-5;-0.300965339
JURKAT;65061;CDK15;cyclin-dependent kinase 15;-4;-0.517614037
JURKAT;23345;SYNE1;spectrin repeat containing, nuclear envelope 1;-4;-0.337346073
JURKAT;7084;TK2;thymidine kinase 2, mitochondrial;-4;-0.46424209
JURKAT;317705;VN1R5;vomeronasal 1 receptor 5 (gene/pseudogene);-4;-0.604750834
JURKAT;140609;NEK7;NIMA-related kinase 7;-4;-0.261367586
JURKAT;11034;DSTN;destrin (actin depolymerizing factor);-3;-0.22118104
JURKAT;27197;GPR82;G protein-coupled receptor 82;-4;-0.364566239
JURKAT;57105;CYSLTR2;cysteinyl leukotriene receptor 2;-4;-0.478128592
JURKAT;10000;AKT3;v-akt murine thymoma viral oncogene homolog 3;-3;-0.309811799
JURKAT;10020;GNE;glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase;-3;-0.270930289
JURKAT;10324;KLHL41;kelch-like family member 41;-8;-0.34591738
JURKAT;2585;GALK2;galactokinase 2;-3;-0.267710458
JURKAT;22948;CCT5;chaperonin containing TCP1, subunit 5 (epsilon);-3;-0.16541995
JURKAT;151556;GPR155;G protein-coupled receptor 155;-4;-0.347825804
JURKAT;27445;PCLO;piccolo presynaptic cytomatrix protein;-3;-0.358417443
JURKAT;8575;PRKRA;protein kinase, interferon-inducible double stranded RNA dependent activator;-4;-0.367181735
JURKAT;1524;CX3CR1;chemokine (C-X3-C motif) receptor 1;-5;-0.234616467
JURKAT;29110;TBK1;TANK-binding kinase 1;-4;-0.29012518
JURKAT;27295;PDLIM3;PDZ and LIM domain 3;-3;-0.2977788
JURKAT;23175;LPIN1;lipin 1;-3;-0.198653575
JURKAT;54329;GPR85;G protein-coupled receptor 85;-4;-0.247530365
JURKAT;9578;CDC42BPB;CDC42 binding protein kinase beta (DMPK-like);-3;-0.2982677
JURKAT;29909;GPR171;G protein-coupled receptor 171;-3;-0.216345337
JURKAT;10540;DCTN2;dynactin 2 (p50);-3;-0.285891561
JURKAT;22858;ICK;intestinal cell (MAK-like) kinase;-4;-0.552427714
JURKAT;30849;PIK3R4;phosphoinositide-3-kinase, regulatory subunit 4;-3;-0.354089042
JURKAT;4651;MYO10;myosin X;-3;-0.24155138
JURKAT;2444;FRK;fyn-related Src family tyrosine kinase;-4;-0.233948905
JURKAT;55366;LGR4;leucine-rich repeat containing G protein-coupled receptor 4;-4;-0.184777966
JURKAT;5567;PRKACB;protein kinase, cAMP-dependent, catalytic, beta;-3;-0.275272742
JURKAT;5569;PKIA;protein kinase (cAMP-dependent, catalytic) inhibitor alpha;-3;-0.150727461
JURKAT;5165;PDK3;pyruvate dehydrogenase kinase, isozyme 3;-5;-0.228102193
JURKAT;3358;HTR2C;5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled;-3;-0.194173866
JURKAT;5610;EIF2AK2;eukaryotic translation initiation factor 2-alpha kinase 2;-3;-0.236481732
JURKAT;54986;ULK4;unc-51 like kinase 4;-4;-0.290483464
JURKAT;55351;STK32B;serine/threonine kinase 32B;-3;-0.423935609
JURKAT;8737;RIPK1;receptor (TNFRSF)-interacting serine-threonine kinase 1;-3;-0.140557804
JURKAT;55917;CTTNBP2NL;CTTNBP2 N-terminal like;-3;-0.387642098
JURKAT;5255;PHKA1;phosphorylase kinase, alpha 1 (muscle);-3;-0.410350668
JURKAT;8549;LGR5;leucine-rich repeat containing G protein-coupled receptor 5;-3;-0.169251552
JURKAT;79339;OR51B4;olfactory receptor, family 51, subfamily B, member 4;-3;-0.202369058
JURKAT;7402;UTRN;utrophin;-3;-0.358659381
JURKAT;9287;TAAR2;trace amine associated receptor 2;-5;-0.171333791
JURKAT;55872;PBK;PDZ binding kinase;-7;-0.320535449
JURKAT;1234;CCR5;chemokine (C-C motif) receptor 5 (gene/pseudogene);-4;-0.093096206
JURKAT;196385;DNAH10;dynein, axonemal, heavy chain 10;3;0.148517778
JURKAT;81491;GPR63;G protein-coupled receptor 63;-4;-0.292132975
JURKAT;51755;CDK12;cyclin-dependent kinase 12;-3;-0.162041693
JURKAT;10128;LRPPRC;leucine-rich pentatricopeptide repeat containing;3;0.089908189
JURKAT;51361;HOOK1;hook microtubule-tethering protein 1;-4;-0.11861623
JURKAT;83551;TAAR8;trace amine associated receptor 8;-3;-0.189040314
JURKAT;51727;CMPK1;cytidine monophosphate (UMP-CMP) kinase 1, cytosolic;3;0.137175175
JURKAT;695;BTK;Bruton agammaglobulinemia tyrosine kinase;-3;-0.321958013
JURKAT;347240;KIF24;kinesin family member 24;3;0.024149582
JURKAT;8507;ENC1;ectodermal-neural cortex 1 (with BTB domain);3;0.216160906
JURKAT;120065;OR5P2;olfactory receptor, family 5, subfamily P, member 2;-4;-0.167336595
JURKAT;51463;GPR89B;G protein-coupled receptor 89B;4;0.248468381
JURKAT;203447;NRK;Nik related kinase;4;0.138675729
JURKAT;6788;STK3;serine/threonine kinase 3;3;0.318276873
JURKAT;1268;CNR1;cannabinoid receptor 1 (brain);7;0.214893622
JURKAT;8729;GBF1;golgi brefeldin A resistant guanine nucleotide exchange factor 1;3;0.121840641
JURKAT;90;ACVR1;activin A receptor, type I;-4;-0.033419787
JURKAT;4986;OPRK1;opioid receptor, kappa 1;3;0.270722917
JURKAT;81697;OR2B2;olfactory receptor, family 2, subfamily B, member 2;3;0.187433406
JURKAT;7855;FZD5;frizzled class receptor 5;3;0.105164848
JURKAT;219899;TBCEL;tubulin folding cofactor E-like;3;0.348146149
JURKAT;5576;PRKAR2A;protein kinase, cAMP-dependent, regulatory, type II, alpha;3;0.30800627
JURKAT;2587;GALR1;galanin receptor 1;3;0.314512473
JURKAT;25809;TTLL1;tubulin tyrosine ligase-like family member 1;3;0.013689358
JURKAT;4752;NEK3;NIMA-related kinase 3;3;0.194268348
JURKAT;9493;KIF23;kinesin family member 23;5;0.300204641
JURKAT;8476;CDC42BPA;CDC42 binding protein kinase alpha (DMPK-like);3;0.301342886
JURKAT;2213;FCGR2B;Fc fragment of IgG, low affinity IIb, receptor (CD32);3;0.348825422
JURKAT;81797;OR12D3;olfactory receptor, family 12, subfamily D, member 3;3;0.18309122
JURKAT;5612;PRKRIR;protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor);3;0.119717771
JURKAT;9706;ULK2;unc-51 like autophagy activating kinase 2;4;0.179315483
JURKAT;26476;OR10J1;olfactory receptor, family 10, subfamily J, member 1;5;0.249991986
JURKAT;23026;MYO16;myosin XVI;4;0.340880367
JURKAT;185;AGTR1;angiotensin II receptor, type 1;4;0.411232688
JURKAT;5651;TMPRSS15;transmembrane protease, serine 15;3;0.310149675
JURKAT;51347;TAOK3;TAO kinase 3;3;0.316542764
JURKAT;9833;MELK;maternal embryonic leucine zipper kinase;3;0.184402485
JURKAT;4217;MAP3K5;mitogen-activated protein kinase kinase kinase 5;-3;-0.036643652
JURKAT;57763;ANKRA2;ankyrin repeat, family A (RFXANK-like), 2;3;0.170546467
JURKAT;27229;TUBGCP4;tubulin, gamma complex associated protein 4;3;0.361513454
JURKAT;558;AXL;AXL receptor tyrosine kinase;-3;-0.10177607
JURKAT;5578;PRKCA;protein kinase C, alpha;3;0.357047107
JURKAT;5891;MOK;MOK protein kinase;3;0.167906069
JURKAT;442721;LMOD2;leiomodin 2 (cardiac);4;0.246176674
JURKAT;54558;SPATA6;spermatogenesis associated 6;4;0.361665419
JURKAT;58480;RHOU;ras homolog family member U;5;0.269693558
JURKAT;53829;P2RY13;purinergic receptor P2Y, G-protein coupled, 13;4;0.123001192
JURKAT;5328;PLAU;plasminogen activator, urokinase;4;0.54242231
JURKAT;79884;MAP9;microtubule-associated protein 9;4;0.314301879
JURKAT;5737;PTGFR;prostaglandin F receptor (FP);3;0.097469305
JURKAT;23705;CADM1;cell adhesion molecule 1;-3;-0.189467706
JURKAT;1021;CDK6;cyclin-dependent kinase 6;4;0.438428188
JURKAT;256356;GK5;glycerol kinase 5 (putative);3;0.247490933
JURKAT;83992;CTTNBP2;cortactin binding protein 2;4;0.433070572
JURKAT;1607;DGKB;diacylglycerol kinase, beta 90kDa;4;0.282893741
JURKAT;5286;PIK3C2A;phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha;4;0.285175684
JURKAT;51135;IRAK4;interleukin-1 receptor-associated kinase 4;3;0.299890292
JURKAT;1235;CCR6;chemokine (C-C motif) receptor 6;4;0.563189682
JURKAT;1147;CHUK;conserved helix-loop-helix ubiquitous kinase;3;0.292102596
JURKAT;1030;CDKN2B;cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4);3;0.158575552
JURKAT;9451;EIF2AK3;eukaryotic translation initiation factor 2-alpha kinase 3;4;0.538836974
JURKAT;7533;YWHAH;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta;3;0.259468273
JURKAT;353345;GPR141;G protein-coupled receptor 141;4;0.415518753
JURKAT;25778;DSTYK;dual serine/threonine and tyrosine protein kinase;3;0.352944121
JURKAT;26529;OR12D2;olfactory receptor, family 12, subfamily D, member 2 (gene/pseudogene);3;0.285943664
JURKAT;1608;DGKG;diacylglycerol kinase, gamma 90kDa;-3;-0.144013849
JURKAT;4168;MCF2;MCF.2 cell line derived transforming sequence;4;0.460622113
JURKAT;10625;IVNS1ABP;influenza virus NS1A binding protein;4;0.186260366
JURKAT;11275;KLHL2;kelch-like family member 2;4;0.799507992
JURKAT;55914;ERBB2IP;erbb2 interacting protein;6;0.280077115
JURKAT;2919;CXCL1;chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha);5;0.443346145
JURKAT;121512;FGD4;FYVE, RhoGEF and PH domain containing 4;3;0.236489803
JURKAT;9934;P2RY14;purinergic receptor P2Y, G-protein coupled, 14;5;0.34883081
JURKAT;8323;FZD6;frizzled class receptor 6;5;0.546500998
JURKAT;5602;MAPK10;mitogen-activated protein kinase 10;5;0.500506246
JURKAT;23235;SIK2;salt-inducible kinase 2;6;0.340353259
JURKAT;3717;JAK2;Janus kinase 2;5;0.406004284
JURKAT;8322;FZD4;frizzled class receptor 4;4;0.467227888
JURKAT;165829;GPR156;G protein-coupled receptor 156;3;0.574189537
JURKAT;10395;DLC1;DLC1 Rho GTPase activating protein;3;0.26055151
JURKAT;56923;NMUR2;neuromedin U receptor 2;3;0.442335055
JURKAT;1633;DCK;deoxycytidine kinase;4;0.260766709
JURKAT;387638;C10orf113;chromosome 10 open reading frame 113;3;0.546584013
JURKAT;3885;KRT34;keratin 34, type I;3;0.463466583
JURKAT;51447;IP6K2;inositol hexakisphosphate kinase 2;3;0.181208978
JURKAT;659;BMPR2;bone morphogenetic protein receptor, type II (serine/threonine kinase);3;0.32800014
JURKAT;56171;DNAH7;dynein, axonemal, heavy chain 7;5;0.327828929
JURKAT;6752;SSTR2;somatostatin receptor 2;4;0.215214876
JURKAT;27443;CECR2;cat eye syndrome chromosome region, candidate 2;4;0.633601081
JURKAT;889;KRIT1;KRIT1, ankyrin repeat containing;3;0.454457968
JURKAT;55860;ACTR10;actin-related protein 10 homolog (S. cerevisiae);3;0.296925078
JURKAT;27185;DISC1;disrupted in schizophrenia 1;3;0.261196913
JURKAT;59340;HRH4;histamine receptor H4;7;0.408318183
JURKAT;1241;LTB4R;leukotriene B4 receptor;3;0.366176545
JURKAT;10575;CCT4;chaperonin containing TCP1, subunit 4 (delta);5;0.376015907
JURKAT;51719;CAB39;calcium binding protein 39;4;0.359863193
JURKAT;8826;IQGAP1;IQ motif containing GTPase activating protein 1;4;0.472938337
JURKAT;23683;PRKD3;protein kinase D3;6;0.430009777
JURKAT;89882;TPD52L3;tumor protein D52-like 3;4;0.463872092
JURKAT;840;CASP7;caspase 7, apoptosis-related cysteine peptidase;3;0.331085342
JURKAT;79858;NEK11;NIMA-related kinase 11;5;0.516599178
JURKAT;6683;SPAST;spastin;5;0.404165901
JURKAT;55359;STYK1;serine/threonine/tyrosine kinase 1;4;0.216443107
JURKAT;1267;CNP;2',3'-cyclic nucleotide 3' phosphodiesterase;3;0.704115455
JURKAT;131118;DNAJC19;DnaJ (Hsp40) homolog, subfamily C, member 19;7;0.584105866
JURKAT;805;CALM2;calmodulin 2 (phosphorylase kinase, delta);3;0.387605027
JURKAT;8243;SMC1A;structural maintenance of chromosomes 1A;5;0.503290314
JURKAT;157;ADRBK2;adrenergic, beta, receptor kinase 2;5;0.26853562
JURKAT;9891;NUAK1;NUAK family, SNF1-like kinase, 1;4;0.419115515
JURKAT;23344;ESYT1;extended synaptotagmin-like protein 1;3;0.467315087
JURKAT;257019;FRMD3;FERM domain containing 3;3;0.436059561
JURKAT;50808;AK3;adenylate kinase 3;4;0.534559009
JURKAT;23118;TAB2;TGF-beta activated kinase 1/MAP3K7 binding protein 2;3;0.491720919
JURKAT;1459;CSNK2A2;casein kinase 2, alpha prime polypeptide;3;0.416718324
JURKAT;70;ACTC1;actin, alpha, cardiac muscle 1;3;0.188962557
JURKAT;51421;AMOTL2;angiomotin like 2;3;0.340446971
JURKAT;152110;NEK10;NIMA-related kinase 10;4;0.390015859
JURKAT;1130;LYST;lysosomal trafficking regulator;3;0.435567343
JURKAT;341676;NEK5;NIMA-related kinase 5;3;0.371178666
JURKAT;23406;COTL1;coactosin-like F-actin binding protein 1;4;0.351063958
JURKAT;643751;CDC42P6;cell division cycle 42 pseudogene 6;4;0.52129343
JURKAT;9201;DCLK1;doublecortin-like kinase 1;3;0.441291743
JURKAT;2849;GPR26;G protein-coupled receptor 26;3;0.441981864
JURKAT;5058;PAK1;p21 protein (Cdc42/Rac)-activated kinase 1;3;0.401944882
JURKAT;6443;SGCB;sarcoglycan, beta (43kDa dystrophin-associated glycoprotein);4;0.378598976
JURKAT;29119;CTNNA3;catenin (cadherin-associated protein), alpha 3;5;0.565412508
JURKAT;54474;KRT20;keratin 20, type I;5;0.618963395
JURKAT;440275;EIF2AK4;eukaryotic translation initiation factor 2 alpha kinase 4;5;0.546737043
JURKAT;2775;GNAO1;guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O;5;0.632644349
JURKAT;1073;CFL2;cofilin 2 (muscle);6;0.33385842
JURKAT;4158;MC2R;melanocortin 2 receptor (adrenocorticotropic hormone);3;0.44020408
JURKAT;8445;DYRK2;dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2;5;0.221108365
JURKAT;5289;PIK3C3;phosphatidylinositol 3-kinase, catalytic subunit type 3;4;0.484367369
JURKAT;9815;GIT2;G protein-coupled receptor kinase interacting ArfGAP 2;4;0.669210342
JURKAT;10529;NEBL;nebulette;4;0.643063325
JURKAT;27102;EIF2AK1;eukaryotic translation initiation factor 2-alpha kinase 1;4;0.750889527
JURKAT;187;APLNR;apelin receptor;3;0.531049516
JURKAT;5500;PPP1CB;protein phosphatase 1, catalytic subunit, beta isozyme;8;0.420788046
JURKAT;6840;SVIL;supervillin;3;0.649048571
JURKAT;5217;PFN2;profilin 2;4;0.42092115
JURKAT;10161;LPAR6;lysophosphatidic acid receptor 6;4;0.653829258
JURKAT;891;CCNB1;cyclin B1;3;0.588639724
JURKAT;54429;TAS2R5;taste receptor, type 2, member 5;6;0.674734228
JURKAT;1832;DSP;desmoplakin;3;0.34184215
JURKAT;4750;NEK1;NIMA-related kinase 1;5;0.361757594
JURKAT;79345;OR51B2;olfactory receptor, family 51, subfamily B, member 2 (gene/pseudogene);4;0.425870297
JURKAT;139741;ACTRT1;actin-related protein T1;3;0.526831468
JURKAT;10800;CYSLTR1;cysteinyl leukotriene receptor 1;4;0.559294052
JURKAT;8621;CDK13;cyclin-dependent kinase 13;4;0.569140317
JURKAT;57669;EPB41L5;erythrocyte membrane protein band 4.1 like 5;4;0.473401873
JURKAT;6502;SKP2;S-phase kinase-associated protein 2, E3 ubiquitin protein ligase;3;0.623880345
JURKAT;9472;AKAP6;A kinase (PRKA) anchor protein 6;3;0.446169627
JURKAT;57144;PAK7;p21 protein (Cdc42/Rac)-activated kinase 7;4;0.777489288
JURKAT;57211;ADGRG6;adhesion G protein-coupled receptor G6;5;0.462247401
JURKAT;8678;BECN1;beclin 1, autophagy related;4;0.782779079
JURKAT;5295;PIK3R1;phosphoinositide-3-kinase, regulatory subunit 1 (alpha);5;0.622735314
JURKAT;2322;FLT3;fms-related tyrosine kinase 3;6;0.564065984
JURKAT;55361;PI4K2A;phosphatidylinositol 4-kinase type 2 alpha;4;0.66238165
JURKAT;55607;PPP1R9A;protein phosphatase 1, regulatory subunit 9A;3;0.290231242
JURKAT;30011;SH3KBP1;SH3-domain kinase binding protein 1;5;0.800744194
JURKAT;283455;KSR2;kinase suppressor of ras 2;4;0.608938746
JURKAT;153;ADRB1;adrenoceptor beta 1;4;0.481948987
JURKAT;2015;ADGRE1;adhesion G protein-coupled receptor E1;4;0.395804313
JURKAT;1456;CSNK1G3;casein kinase 1, gamma 3;5;0.618499261
JURKAT;7010;TEK;TEK tyrosine kinase, endothelial;4;1.059355924
JURKAT;4751;NEK2;NIMA-related kinase 2;3;0.326635766
JURKAT;326342;ADGRE4P;adhesion G protein-coupled receptor E4, pseudogene;3;0.658891947
JURKAT;120776;OR2D2;olfactory receptor, family 2, subfamily D, member 2;3;0.573559667
JURKAT;23012;STK38L;serine/threonine kinase 38 like;3;0.386747311
JURKAT;5592;PRKG1;protein kinase, cGMP-dependent, type I;5;0.753235776
JURKAT;64781;CERK;ceramide kinase;3;0.580205127
JURKAT;1841;DTYMK;deoxythymidylate kinase (thymidylate kinase);3;0.634192906
JURKAT;11035;RIPK3;receptor-interacting serine-threonine kinase 3;3;0.304703696
JURKAT;10663;CXCR6;chemokine (C-X-C motif) receptor 6;4;0.653110251
JURKAT;10769;PLK2;polo-like kinase 2;4;0.864084182
JURKAT;6595;SMARCA2;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2;4;0.850908814
JURKAT;8632;DNAH17;dynein, axonemal, heavy chain 17;3;0.420271194
JURKAT;7273;TTN;titin;9;0.539839757
JURKAT;27019;DNAI1;dynein, axonemal, intermediate chain 1;5;0.825134545
JURKAT;389840;MAP3K15;mitogen-activated protein kinase kinase kinase 15;5;0.81922246
JURKAT;80018;NAA25;N(alpha)-acetyltransferase 25, NatB auxiliary subunit;4;0.565926167
JURKAT;9943;OXSR1;oxidative stress responsive 1;4;0.59135774
JURKAT;29922;NME7;NME/NM23 family member 7;5;0.718088684
JURKAT;4763;NF1;neurofibromin 1;4;0.443616811
JURKAT;2042;EPHA3;EPH receptor A3;6;0.506062386
JURKAT;5586;PKN2;protein kinase N2;5;0.543034111
JURKAT;2044;EPHA5;EPH receptor A5;5;0.620197826
JURKAT;143496;OR52B4;olfactory receptor, family 52, subfamily B, member 4 (gene/pseudogene);3;0.739520053
JURKAT;55567;DNAH3;dynein, axonemal, heavy chain 3;4;0.664461853
JURKAT;5599;MAPK8;mitogen-activated protein kinase 8;5;0.855585557
JURKAT;6198;RPS6KB1;ribosomal protein S6 kinase, 70kDa, polypeptide 1;7;0.783941864
JURKAT;4140;MARK3;MAP/microtubule affinity-regulating kinase 3;4;0.649162745
JURKAT;57556;SEMA6A;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A;5;0.996992746
JURKAT;9172;MYOM2;myomesin 2;5;0.804809639
JURKAT;1951;CELSR3;cadherin, EGF LAG seven-pass G-type receptor 3;5;0.997638667
JURKAT;23603;CORO1C;coronin, actin binding protein, 1C;5;0.69286392
JURKAT;84517;ACTRT3;actin-related protein T3;4;0.783101986
JURKAT;2911;GRM1;glutamate receptor, metabotropic 1;3;0.708757362
JURKAT;3853;KRT6A;keratin 6A, type II;4;0.964167028
JURKAT;283629;TSSK4;testis-specific serine kinase 4;4;0.700388102
JURKAT;1910;EDNRB;endothelin receptor type B;6;0.663622038
JURKAT;140901;STK35;serine/threonine kinase 35;5;1.118418655
JURKAT;6416;MAP2K4;mitogen-activated protein kinase kinase 4;4;0.954597664
JURKAT;221662;RBM24;RNA binding motif protein 24;3;0.524879026
JURKAT;440730;TRIM67;tripartite motif containing 67;6;1.195639211
JURKAT;5062;PAK2;p21 protein (Cdc42/Rac)-activated kinase 2;11;0.905814607
JURKAT;397;ARHGDIB;Rho GDP dissociation inhibitor (GDI) beta;7;0.944701217
MOLT3;5170;PDPK1;3-phosphoinositide dependent protein kinase 1;-7;-1.235497312
MOLT3;3281;HSBP1;heat shock factor binding protein 1;-3;-1.156913886
MOLT3;23049;SMG1;SMG1 phosphatidylinositol 3-kinase-related kinase;-5;-0.958545645
MOLT3;1909;EDNRA;endothelin receptor type A;-5;-0.900171021
MOLT3;27289;RND1;Rho family GTPase 1;-4;-1.02674545
MOLT3;4893;NRAS;neuroblastoma RAS viral (v-ras) oncogene homolog;-6;-0.656562985
MOLT3;5290;PIK3CA;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha;-3;-0.727942304
MOLT3;10324;KLHL41;kelch-like family member 41;-4;-0.59115418
MOLT3;8999;CDKL2;cyclin-dependent kinase-like 2 (CDC2-related kinase);-4;-0.905323416
MOLT3;58480;RHOU;ras homolog family member U;-3;-0.577261908
MOLT3;55638;SYBU;syntabulin (syntaxin-interacting);-5;-0.775231659
MOLT3;983;CDK1;cyclin-dependent kinase 1;-4;-0.702978415
MOLT3;192666;KRT24;keratin 24, type I;-4;-0.590893702
MOLT3;10611;PDLIM5;PDZ and LIM domain 5;-6;-0.432759812
MOLT3;7272;TTK;TTK protein kinase;-6;-0.463265944
MOLT3;10580;SORBS1;sorbin and SH3 domain containing 1;-4;-0.487936859
MOLT3;5747;PTK2;protein tyrosine kinase 2;-7;-0.479076253
MOLT3;10886;NPFFR2;neuropeptide FF receptor 2;-4;-0.421471058
MOLT3;56923;NMUR2;neuromedin U receptor 2;-7;-0.742436928
MOLT3;357;SHROOM2;shroom family member 2;-3;-0.496494763
MOLT3;7534;YWHAZ;tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta;-3;-0.644965039
MOLT3;729230;CCR2;chemokine (C-C motif) receptor 2;-3;-0.496217026
MOLT3;10888;GPR83;G protein-coupled receptor 83;-5;-0.716260372
MOLT3;8899;PRPF4B;pre-mRNA processing factor 4B;-5;-0.504781901
MOLT3;6002;RGS12;regulator of G-protein signaling 12;-3;-0.53700472
MOLT3;127933;UHMK1;U2AF homology motif (UHM) kinase 1;-5;-0.813280998
MOLT3;23299;BICD2;bicaudal D homolog 2 (Drosophila);-4;-0.527389085
MOLT3;9287;TAAR2;trace amine associated receptor 2;-3;-0.336626531
MOLT3;23345;SYNE1;spectrin repeat containing, nuclear envelope 1;-3;-0.557592981
MOLT3;4142;MAS1;MAS1 proto-oncogene, G protein-coupled receptor;-3;-0.303029846
MOLT3;3845;KRAS;Kirsten rat sarcoma viral oncogene homolog;-3;-0.47745527
MOLT3;26707;OR2J2;olfactory receptor, family 2, subfamily J, member 2;-3;-0.526412662
MOLT3;10128;LRPPRC;leucine-rich pentatricopeptide repeat containing;-5;-0.40575397
MOLT3;51135;IRAK4;interleukin-1 receptor-associated kinase 4;-3;-0.536633928
MOLT3;5565;PRKAB2;protein kinase, AMP-activated, beta 2 non-catalytic subunit;-4;-0.60592545
MOLT3;4830;NME1;NME/NM23 nucleoside diphosphate kinase 1;-4;-0.426362963
MOLT3;23022;PALLD;palladin, cytoskeletal associated protein;-3;-0.361492541
MOLT3;8575;PRKRA;protein kinase, interferon-inducible double stranded RNA dependent activator;-3;-0.320299714
MOLT3;57512;GPR158;G protein-coupled receptor 158;-6;-0.713721548
MOLT3;11043;MID2;midline 2;-3;-0.412482298
MOLT3;3702;ITK;IL2-inducible T-cell kinase;-3;-0.381405679
MOLT3;29767;TMOD2;tropomodulin 2 (neuronal);-4;-0.580473402
MOLT3;1432;MAPK14;mitogen-activated protein kinase 14;-4;-0.491602728
MOLT3;4116;MAGOH;mago-nashi homolog, proliferation-associated (Drosophila);-4;-0.410859341
MOLT3;10671;DCTN6;dynactin 6;-3;-0.281207905
MOLT3;387;RHOA;ras homolog family member A;-3;-0.284345518
MOLT3;25932;CLIC4;chloride intracellular channel 4;-5;-0.531826483
MOLT3;51704;GPRC5B;G protein-coupled receptor, class C, group 5, member B;-4;-0.517962973
MOLT3;121512;FGD4;FYVE, RhoGEF and PH domain containing 4;-4;-0.785608223
MOLT3;4703;NEB;nebulin;-5;-0.404672653
MOLT3;26716;OR2H1;olfactory receptor, family 2, subfamily H, member 1;-3;-0.384760694
MOLT3;124274;GPR139;G protein-coupled receptor 139;-4;-0.668121142
MOLT3;10000;AKT3;v-akt murine thymoma viral oncogene homolog 3;-3;-0.36390706
MOLT3;150094;SIK1;salt-inducible kinase 1;-4;-0.423266802
MOLT3;5562;PRKAA1;protein kinase, AMP-activated, alpha 1 catalytic subunit;-8;-0.431381744
MOLT3;5500;PPP1CB;protein phosphatase 1, catalytic subunit, beta isozyme;-3;-0.443982588
MOLT3;3361;HTR5A;5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled;-4;-0.653022867
MOLT3;4067;LYN;LYN proto-oncogene, Src family tyrosine kinase;-3;-0.439429001
MOLT3;81696;OR5V1;olfactory receptor, family 5, subfamily V, member 1;-5;-0.323997514
MOLT3;5294;PIK3CG;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma;-6;-0.340892048
MOLT3;10787;NCKAP1;NCK-associated protein 1;-4;-0.478418612
MOLT3;23678;SGK3;serum/glucocorticoid regulated kinase family, member 3;-3;-0.218921602
MOLT3;6711;SPTBN1;spectrin, beta, non-erythrocytic 1;-3;-0.214688093
MOLT3;9748;SLK;STE20-like kinase;-4;-0.314013263
MOLT3;5291;PIK3CB;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta;-3;-0.290713085
MOLT3;55589;BMP2K;BMP2 inducible kinase;-3;-0.303848166
MOLT3;23012;STK38L;serine/threonine kinase 38 like;-3;-0.298359703
MOLT3;27;ABL2;ABL proto-oncogene 2, non-receptor tyrosine kinase;-3;-0.256387251
MOLT3;5563;PRKAA2;protein kinase, AMP-activated, alpha 2 catalytic subunit;-3;-0.38132468
MOLT3;11127;KIF3A;kinesin family member 3A;-3;-0.334666619
MOLT3;3832;KIF11;kinesin family member 11;-4;-0.497127992
MOLT3;134864;TAAR1;trace amine associated receptor 1;-5;-0.219192559
MOLT3;64123;ADGRL4;adhesion G protein-coupled receptor L4;-4;-0.401313595
MOLT3;2919;CXCL1;chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha);-3;-0.242277027
MOLT3;5651;TMPRSS15;transmembrane protease, serine 15;-3;-0.249584219
MOLT3;4646;MYO6;myosin VI;-3;-0.115160694
MOLT3;1633;DCK;deoxycytidine kinase;3;0.029378831
MOLT3;8502;PKP4;plakophilin 4;-3;-0.231764991
MOLT3;2358;FPR2;formyl peptide receptor 2;-3;-0.367733252
MOLT3;53829;P2RY13;purinergic receptor P2Y, G-protein coupled, 13;-5;-0.354576508
MOLT3;2042;EPHA3;EPH receptor A3;-3;-0.406848299
MOLT3;4915;NTRK2;neurotrophic tyrosine kinase, receptor, type 2;-3;-0.156847248
MOLT3;84451;KIAA1804;mixed lineage kinase 4;-3;-0.296417554
MOLT3;3352;HTR1D;5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled;-5;-0.191517786
MOLT3;1456;CSNK1G3;casein kinase 1, gamma 3;-4;-0.251944282
MOLT3;817;CAMK2D;calcium/calmodulin-dependent protein kinase II delta;-3;-0.098046708
MOLT3;5166;PDK4;pyruvate dehydrogenase kinase, isozyme 4;-4;-0.179272576
MOLT3;64781;CERK;ceramide kinase;-3;-0.280309448
MOLT3;4889;NPY5R;neuropeptide Y receptor Y5;-5;-0.199406029
MOLT3;2845;GPR22;G protein-coupled receptor 22;-3;-0.114137483
MOLT3;10798;OR5I1;olfactory receptor, family 5, subfamily I, member 1;-3;-0.199783426
MOLT3;55342;STRBP;spermatid perinuclear RNA binding protein;3;0.178814981
MOLT3;5288;PIK3C2G;phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma;3;0.297947433
MOLT3;84056;KATNAL1;katanin p60 subunit A-like 1;-3;-0.1645334
MOLT3;8780;RIOK3;RIO kinase 3;3;0.282637963
MOLT3;657;BMPR1A;bone morphogenetic protein receptor, type IA;3;0.284777879
MOLT3;273;AMPH;amphiphysin;4;0.365028753
MOLT3;51727;CMPK1;cytidine monophosphate (UMP-CMP) kinase 1, cytosolic;-3;-0.165117128
MOLT3;1164;CKS2;CDC28 protein kinase regulatory subunit 2;6;0.291807835
MOLT3;30849;PIK3R4;phosphoinositide-3-kinase, regulatory subunit 4;3;0.326857005
MOLT3;6259;RYK;receptor-like tyrosine kinase;3;0.338645049
MOLT3;54474;KRT20;keratin 20, type I;3;0.139031733
MOLT3;114793;FMNL2;formin-like 2;3;0.182151729
MOLT3;5128;CDK17;cyclin-dependent kinase 17;5;0.480992302
MOLT3;5733;PTGER3;prostaglandin E receptor 3 (subtype EP3);5;0.228891174
MOLT3;2241;FER;fer (fps/fes related) tyrosine kinase;3;0.28429848
MOLT3;9863;MAGI2;membrane associated guanylate kinase, WW and PDZ domain containing 2;3;0.462150842
MOLT3;11218;DDX20;DEAD (Asp-Glu-Ala-Asp) box polypeptide 20;3;0.443960492
MOLT3;10114;HIPK3;homeodomain interacting protein kinase 3;3;0.458352073
MOLT3;8727;CTNNAL1;catenin (cadherin-associated protein), alpha-like 1;-3;-0.073867272
MOLT3;660;BMX;BMX non-receptor tyrosine kinase;5;0.442738258
MOLT3;1756;DMD;dystrophin;3;0.405801417
MOLT3;84109;QRFPR;pyroglutamylated RFamide peptide receptor;3;0.236862461
MOLT3;2444;FRK;fyn-related Src family tyrosine kinase;3;0.375950135
MOLT3;1607;DGKB;diacylglycerol kinase, beta 90kDa;3;0.234637695
MOLT3;55759;WDR12;WD repeat domain 12;3;0.445943503
MOLT3;375449;MAST4;microtubule associated serine/threonine kinase family member 4;3;0.537624116
MOLT3;10783;NEK6;NIMA-related kinase 6;3;0.407580881
MOLT3;25998;IBTK;inhibitor of Bruton agammaglobulinemia tyrosine kinase;3;0.147871499
MOLT3;347240;KIF24;kinesin family member 24;3;0.293763485
MOLT3;8526;DGKE;diacylglycerol kinase, epsilon 64kDa;3;0.286434686
MOLT3;23122;CLASP2;cytoplasmic linker associated protein 2;3;0.256341541
MOLT3;1063;CENPF;centromere protein F, 350/400kDa;3;0.303998439
MOLT3;1030;CDKN2B;cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4);3;0.422298665
MOLT3;10769;PLK2;polo-like kinase 2;3;0.516953791
MOLT3;10982;MAPRE2;microtubule-associated protein, RP/EB family, member 2;5;0.311824078
MOLT3;160851;DGKH;diacylglycerol kinase, eta;3;0.361631348
MOLT3;64431;ACTR6;ARP6 actin-related protein 6 homolog (yeast);3;0.256829869
MOLT3;2825;GPR1;G protein-coupled receptor 1;3;0.244680637
MOLT3;6840;SVIL;supervillin;3;0.464216165
MOLT3;1017;CDK2;cyclin-dependent kinase 2;4;0.464811544
MOLT3;5593;PRKG2;protein kinase, cGMP-dependent, type II;5;0.394552215
MOLT3;5586;PKN2;protein kinase N2;3;0.360230675
MOLT3;53637;S1PR5;sphingosine-1-phosphate receptor 5;3;0.2741504
MOLT3;23235;SIK2;salt-inducible kinase 2;7;0.369689547
MOLT3;2770;GNAI1;guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1;3;0.287353375
MOLT3;90;ACVR1;activin A receptor, type I;3;0.199813738
MOLT3;81788;NUAK2;NUAK family, SNF1-like kinase, 2;3;0.301343858
MOLT3;222545;GPRC6A;G protein-coupled receptor, class C, group 6, member A;5;0.298722675
MOLT3;805;CALM2;calmodulin 2 (phosphorylase kinase, delta);3;0.32830413
MOLT3;8527;DGKD;diacylglycerol kinase, delta 130kDa;3;0.519031543
MOLT3;5062;PAK2;p21 protein (Cdc42/Rac)-activated kinase 2;4;0.432315131
MOLT3;4168;MCF2;MCF.2 cell line derived transforming sequence;3;0.368932059
MOLT3;64111;NPVF;neuropeptide VF precursor;3;0.47421464
MOLT3;4158;MC2R;melanocortin 2 receptor (adrenocorticotropic hormone);3;0.302002251
MOLT3;23683;PRKD3;protein kinase D3;5;0.281629308
MOLT3;5962;RDX;radixin;6;0.475028645
MOLT3;4140;MARK3;MAP/microtubule affinity-regulating kinase 3;4;0.476034455
MOLT3;30011;SH3KBP1;SH3-domain kinase binding protein 1;3;0.335525737
MOLT3;9252;RPS6KA5;ribosomal protein S6 kinase, 90kDa, polypeptide 5;-3;0.22665944
MOLT3;51361;HOOK1;hook microtubule-tethering protein 1;3;0.418809523
MOLT3;6198;RPS6KB1;ribosomal protein S6 kinase, 70kDa, polypeptide 1;4;0.552295201
MOLT3;11329;STK38;serine/threonine kinase 38;4;0.343881421
MOLT3;5217;PFN2;profilin 2;5;0.508072095
MOLT3;5208;PFKFB2;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2;3;0.476467585
MOLT3;8826;IQGAP1;IQ motif containing GTPase activating protein 1;3;0.459765602
MOLT3;8649;LAMTOR3;late endosomal/lysosomal adaptor, MAPK and MTOR activator 3;4;0.513501885
MOLT3;50808;AK3;adenylate kinase 3;4;0.632264806
MOLT3;10788;IQGAP2;IQ motif containing GTPase activating protein 2;4;0.380346204
MOLT3;2915;GRM5;glutamate receptor, metabotropic 5;3;0.350878176
MOLT3;2065;ERBB3;erb-b2 receptor tyrosine kinase 3;3;0.562697977
MOLT3;10097;ACTR2;ARP2 actin-related protein 2 homolog (yeast);4;0.385792202
MOLT3;5165;PDK3;pyruvate dehydrogenase kinase, isozyme 3;3;0.181113659
MOLT3;2841;GPR18;G protein-coupled receptor 18;3;0.523525027
MOLT3;122481;AK7;adenylate kinase 7;3;0.583666515
MOLT3;143496;OR52B4;olfactory receptor, family 52, subfamily B, member 4 (gene/pseudogene);3;0.33940878
MOLT3;1812;DRD1;dopamine receptor D1;3;0.338112015
MOLT3;5599;MAPK8;mitogen-activated protein kinase 8;3;0.754811663
MOLT3;604;BCL6;B-cell CLL/lymphoma 6;4;0.666068748
MOLT3;86;ACTL6A;actin-like 6A;3;0.59877436
MOLT3;5311;PKD2;polycystic kidney disease 2 (autosomal dominant);4;0.437156016
MOLT3;80216;ALPK1;alpha-kinase 1;3;0.563107733
MOLT3;23433;RHOQ;ras homolog family member Q;5;0.342674455
MOLT3;6647;SOD1;superoxide dismutase 1, soluble;3;0.371983222
MOLT3;54112;GPR88;G protein-coupled receptor 88;4;0.466971609
MOLT3;1130;LYST;lysosomal trafficking regulator;6;0.486225803
MOLT3;10395;DLC1;DLC1 Rho GTPase activating protein;3;0.640446861
MOLT3;5891;MOK;MOK protein kinase;3;0.458751961
MOLT3;130271;PLEKHH2;pleckstrin homology domain containing, family H (with MyTH4 domain) member 2;3;0.235494604
MOLT3;56062;KLHL4;kelch-like family member 4;4;0.464377139
MOLT3;10296;MAEA;macrophage erythroblast attacher;3;0.547937918
MOLT3;4829;NMBR;neuromedin B receptor;3;0.382035414
MOLT3;51422;PRKAG2;protein kinase, AMP-activated, gamma 2 non-catalytic subunit;3;0.560349507
MOLT3;4750;NEK1;NIMA-related kinase 1;3;0.400045502
MOLT3;1739;DLG1;discs, large homolog 1 (Drosophila);4;0.437195611
MOLT3;10625;IVNS1ABP;influenza virus NS1A binding protein;5;0.587163768
MOLT3;23175;LPIN1;lipin 1;5;0.793527566
MOLT3;25809;TTLL1;tubulin tyrosine ligase-like family member 1;4;0.433873549
MOLT3;80318;GKAP1;G kinase anchoring protein 1;6;0.540261712
MOLT3;2911;GRM1;glutamate receptor, metabotropic 1;4;0.54780726
MOLT3;2857;GPR34;G protein-coupled receptor 34;8;0.546752033
MOLT3;283446;MYO1H;myosin IH;4;0.509870943
MOLT3;27197;GPR82;G protein-coupled receptor 82;5;0.41902669
MOLT3;1195;CLK1;CDC-like kinase 1;4;0.600955387
MOLT3;84517;ACTRT3;actin-related protein T3;4;0.875299817
MOLT3;27347;STK39;serine threonine kinase 39;6;0.557903179
MOLT3;6793;STK10;serine/threonine kinase 10;4;0.765347091
MOLT3;8382;NME5;NME/NM23 family member 5;3;0.371927929
MOLT3;56670;SUCNR1;succinate receptor 1;8;0.719477986
MOLT3;23097;CDK19;cyclin-dependent kinase 19;6;0.708344951
MOLT3;1901;S1PR1;sphingosine-1-phosphate receptor 1;3;0.532818267
MOLT3;5021;OXTR;oxytocin receptor;4;0.570285652
MOLT3;8678;BECN1;beclin 1, autophagy related;4;0.493708391
MOLT3;9934;P2RY14;purinergic receptor P2Y, G-protein coupled, 14;4;0.677393972
MOLT3;9162;DGKI;diacylglycerol kinase, iota;3;0.55044802
MOLT3;1457;CSNK2A1;casein kinase 2, alpha 1 polypeptide;3;0.511860235
MOLT3;4886;NPY1R;neuropeptide Y receptor Y1;4;0.460041169
MOLT3;55742;PARVA;parvin, alpha;5;0.747512833
MOLT3;5289;PIK3C3;phosphatidylinositol 3-kinase, catalytic subunit type 3;4;0.55797748
MOLT3;6500;SKP1;S-phase kinase-associated protein 1;7;0.593404506
MOLT3;9499;MYOT;myotilin;5;0.618971133
MOLT3;6197;RPS6KA3;ribosomal protein S6 kinase, 90kDa, polypeptide 3;5;0.464099297
MOLT3;397;ARHGDIB;Rho GDP dissociation inhibitor (GDI) beta;3;0.444802697
MOLT3;55450;CAMK2N1;calcium/calmodulin-dependent protein kinase II inhibitor 1;3;0.695519056
MOLT3;6993;DYNLT1;dynein, light chain, Tctex-type 1;4;0.549954881
MOLT3;5108;PCM1;pericentriolar material 1;6;0.82860822
MOLT3;23266;ADGRL2;adhesion G protein-coupled receptor L2;3;0.399489355
MOLT3;81472;OR2C3;olfactory receptor, family 2, subfamily C, member 3;4;0.432364917
MOLT3;545;ATR;ATR serine/threonine kinase;7;0.701303649
MOLT3;5207;PFKFB1;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1;3;0.664976793
MOLT3;55359;STYK1;serine/threonine/tyrosine kinase 1;6;0.645144998
MOLT3;2044;EPHA5;EPH receptor A5;3;0.733377461
MOLT3;80025;PANK2;pantothenate kinase 2;5;0.946316044
MOLT3;5588;PRKCQ;protein kinase C, theta;3;0.583472222
MOLT3;7371;UCK2;uridine-cytidine kinase 2;7;0.675553118
MOLT3;260425;MAGI3;membrane associated guanylate kinase, WW and PDZ domain containing 3;3;0.370976265
MOLT3;166647;ADGRA3;adhesion G protein-coupled receptor A3;4;0.653794754
MOLT3;149420;PDIK1L;PDLIM1 interacting kinase 1 like;3;0.493562753
MOLT3;6443;SGCB;sarcoglycan, beta (43kDa dystrophin-associated glycoprotein);4;0.79638264
MOLT3;624;BDKRB2;bradykinin receptor B2;4;0.675115262
MOLT3;680;BRS3;bombesin-like receptor 3;4;0.730183304
MOLT3;55971;BAIAP2L1;BAI1-associated protein 2-like 1;4;0.656174241
MOLT3;1233;CCR4;chemokine (C-C motif) receptor 4;6;0.968461073
MOLT3;9126;SMC3;structural maintenance of chromosomes 3;6;0.755849182
MOLT3;8766;RAB11A;RAB11A, member RAS oncogene family;4;0.994350845
MOLT3;2620;GAS2;growth arrest-specific 2;8;0.70469416
MOLT3;344387;CDKL4;cyclin-dependent kinase-like 4;4;0.599226097
MOLT3;51447;IP6K2;inositol hexakisphosphate kinase 2;3;1.030861266
MOLT3;57626;KLHL1;kelch-like family member 1;4;1.019627133
MOLT3;5537;PPP6C;protein phosphatase 6, catalytic subunit;8;1.074826341
MOLT3;9451;EIF2AK3;eukaryotic translation initiation factor 2-alpha kinase 3;7;0.698095434